Hatch-Waxman Complaints Down Sharply During Pandemic
Patent suits over abbreviated new drug applications have dropped significantly since the start of 2020 compared to the same time last year due to pharmaceutical companies diverting their attention from developing...To view the full article, register now.
Already a subscriber? Click here to view full article